drugset / Trial / NCT06767735
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will be conducted to compare the efficacy, safety and patient-reported outcome of once-weekly GZR4 and once-daily Insulin Glargine U100 with Non-Insulin Antidiabetic Agents in Insulin-naive Subjects with Type 2 Diabetes Mellitusin.
Timeline
- Start
- 2025-02-17
- Primary completion
- 2026-08-01
- Completion
- 2026-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GZR4 | Unknown | — | Subcutaneous |
| Comparator | Insulin glargine U100 | Protein / enzyme biologic | — | Subcutaneous |